Attachment H -- Federal Register Notice

20820

Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices

Comments maybe submitted
electronically on www.regulations.gov
or by mail to Arnold Chow, Export
Import Bank of the United States, 811
Vermont Ave. NW., Washington, DC
20571.

ADDRESSES:

Titles and
Form Number: EIB 94–08 Notification
and Assignment by Insured to Financial
Institution of Medium Term Export
Credit Insurance Policy.
OMB Number: 3048–xxx.
Type of Review: Regular.
Need and Use: The form transfers the
duties and obligations of the insured
exporter to the financial institution. It
also provides certifications to the
financial institution and Ex-Im Bank
that the financed export transaction
results in a valid, enforceable, and
performing debt obligation. Exporter
policy holders need this form to obtain
financing for their medium term export
sales.
Affected Public: This form affects
entities involved in the export of U.S
goods and services.
Annual Number of Respondents: 50.
Estimated Time per Respondent: 10
minutes.
Government Annual Burden Hours: 5
hours.
Frequency of Reporting or Use: As
needed.

SUPPLEMENTARY INFORMATION:

Sharon A. Whitt,
Agency Clearance Officer.
[FR Doc. 2012–8309 Filed 4–5–12; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

mstockstill on DSK4VPTVN1PROD with NOTICES

Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company

Agency for Healthcare Research and
Quality Agency

The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than April 23,
2012.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice

16:17 Apr 05, 2012

Board of Governors of the Federal Reserve
System, April 3, 2012.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2012–8321 Filed 4–5–12; 8:45 am]

BILLING CODE 6690–01–P

VerDate Mar<15>2010

President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. The Duncan, Hrvol, and Molzen
Families consisting of E. Ray Duncan,
individually and as beneficiary of the
Hardware State Bank 401K Plan and as
beneficiary of the Sullivan Bancshares,
Inc. Employee Savings and Retirement
Plan, together as a group acting in
concert with Sally Foley Duncan and
Sally Foley Duncan, as Trustee of the
John K. Foley Revocable Living Trust
and as beneficiary of the Hardware State
Bank 401K Plan, the John K. Foley
Revocable Living Trust, and Gloria
Foley, all of Lovington, Illinois, and
Paul Michael Hrvol, Jr. and Paul
Michael Hrvol, Jr., as beneficiary of the
Sullivan Bancshares, Inc. Employee
Savings and Retirement Plan, Michelle
Beth Hrvol and Michelle Beth Hrvol, as
beneficiary of the Sullivan Bancshares,
Inc. Employee Savings and Retirement
Plan, all of Sullivan, Illinois, and Roger
Reid Molzen and Roger Reid Molzen, as
beneficiary of the Sullivan Bancshares,
Inc. Employee Savings and Retirement
Plan and Christina DeAnne Molzen, all
of Sullivan, Illinois, collectively as a
group acting in concert, to retain shares
of Moultrie Bancorp, Inc. and thereby
indirectly control Hardware State Bank,
both of Lovington, Illinois.

Jkt 226001

Information Collection Activities:
Proposed Collection; Comment
Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:

This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Synthesis of AHRQ–Funded HAI
Projects.’’ In accordance with the
Paperwork Reduction Act, 44 U.S.C.
3501–3521, AHRQ invites the public to
comment on this proposed information
collection.
DATES: Comments on this notice must be
received by June 5, 2012.
SUMMARY:

PO 00000

Frm 00042

Fmt 4703

Sfmt 4703

Written comments should
be submitted to: Doris Leflcowitz,
Reports Clearance Officer, AHRQ, by
email at [email protected].
gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Leflcowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at [email protected].
SUPPLEMENTARY INFORMATION:
ADDRESSES:

Proposed Project
Synthesis of AHRQ–Funded HAI
Projects
The Agency for Healthcare Research
and Quality (AHRQ) requests that the
Office of Management and Budget
(OMB) approve, under the Paperwork
Reduction Act of 1995, AHRQ’s
collection of information for the
Synthesis of AHRQ–Funded HAI
Projects.
For approximately a decade, AHRQ
has conducted research on preventing
healthcareassociated infections (HAIs),
both internally and through contracts
and grants. AHRQ’s grant- and contractsupported projects have been directed at
the major types of HAIs: Central-lineassociated bloodstream infections
(CLABSI), catheter-associated urinary
tract infections (CAUTI), surgical site
infections (S SI), ventilator-associated
pneumonia (VAP), methicillin-resistant
Staphylococcus aureus (MRSA), and
Clostridium difficile (C. cliff.). Projects
have addressed the problem of HAIs in
diverse healthcare settings, including
hospitals, ambulatory settings
(ambulatory surgery centers, end-stage
renal disease facilities, and outpatient
clinics and offices), and long-term care
facilities. AHRQ’s portfolio of HAI
projects has emphasized a combination
of research and implementation
initiatives. In the latter category, a major
focus of AHRQ’s efforts has been to
deploy tools that can improve provider
performance and reduce HAIs. Based on
the earlier success of the Michigan
Keystone project, AHRQ has funded
projects to implement the
Comprehensive Unit-based Safety
Program (CUSP) to address CLABSI and
CAUTI nationwide. Data are now
emerging that demonstrate the success
of CUSP in reducing CLABSI in
hospitals across the nation.
Between 2007 and 2010, AHRQ
funded 40 contracts and 18 grants
focusing on expanding the HAI
knowledge base and implementing HAI
prevention strategies. Today it is

E:\FR\FM\06APN1.SGM

06APN1

20821

Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices
necessary to look across these projects
in order to (1) identify, document, and
synthesize their findings and results to
ensure that AHRQ, healthcare
professionals, and the public can make
best use of these findings and (2)
identify remaining gaps in the HAI
science base to enable AHRQ to fund
future studies that will address these
needs. The synthesis will draw on
several data sources, including
interviews with project leaders. In
addition to learning about studies that
have not published peer-reviewed
manuscripts, the interviews will enable
the project team to delve into project
details that are not typically available in
publications, such as the project leader’s
motivation for responding to the request
for proposal, challenges faced in
implementing the project, changes in
the project’s delivery schedule or work
plan, experts’ views on how HAI
prevention evidence generated by a
specific project fits into the HAI
research agenda more broadly, and
remaining gaps in the HAI knowledge
base.
AHRQ has contracted with IMPAQ
International, LLC, to develop this
synthesis, identify gaps, and promote
the widespread application of
successful HAI prevention approaches.
This research has the following goals:
(1) Identify and document findings and
synthesize results of AHRQ-funded HAI
projects; (2) Disseminate key findings
from the HAI projects; and (3) Identify
remaining gaps in the HAI knowledge
base.

This study is being conducted by
AHRQ through its contractor, IMPAQ
International, LLC and its subcontractor,
the RAND Corporation, pursuant to
AHRQ’s statutory authority to conduct
and support research and disseminate
information on healthcare and on
systems for the delivery of such care,
including activities with respect to the
quality, effectiveness, efficiency,
appropriateness and value of healthcare
services and with respect to quality
measurement and improvement. 42
U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of this project the
following data collection will be
implemented:
(1) Interviews with contractors—
Interviews will be conducted with the
project leaders (project directors or
project managers) from 40 HAT
contractors. The purpose of these
interviews is to identify (a) key findings,
(b) gaps in knowledge base, (c) lessons
learned, (d) effective approaches for
preventing and reducing HAIs, and e)
opportunities for additional projects
focused on generating and
implementing knowledge on preventing
HAIs.
(2) Interviews with grantees—
Interviews will be conducted with the
project leaders (principal investigators)
from 18 HAI grantees. Similar to the
interviews with contractors, the purpose
of these interviews is to identify (a) key
findings, (b) gaps in knowledge base, (c)
lessons learned, (d) effective approaches

for preventing and reducing HAIs, and
(e) opportunities for additional projects
focused on generating and
implementing knowledge on preventing
HAIs. While the goals of the interviews
with contractors and grantees are
similar, the two audiences require
separate interview protocols because
their funding mechanisms and project
structures differ. For example, contracts
have more structured deliverable
schedules than do grants and grants are
more likely than contracts to be on
investigator-initiated topics.
AHRQ will interview key project
leaders to learn about the processes and
methods used, results achieved, and
lessons learned under the AHRQ-funded
HAI contracts and grants. This
information will enable AHRQ to
identify effective approaches for
preventing and reducing HAIs and for
promoting the widespread application
of these approaches. Finally, collecting
data from these audiences will allow
AHRQ to detect gaps in the HAI science
base and identify opportunities for
additional projects focused on
generating and implementing
knowledge on preventing HAIs.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondent’s time to participate in this
evaluation. Interviews will be
conducted with 40 contractors and 18
grantees and each will last about 90
minutes. The total burden hours are
estimated to be 87.

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Hours per
response

Total burden
hours

Interviews with contractors ..............................................................
Interviews with grantees ..................................................................

40
18

1
1

1.5
1.5

60
27

Total ..........................................................................................

58

n/a

n/a

87

The respondents are the project
leaders, that is, project directors for the
contracts and principal investigators for
the grants. Based on the type of grant
and the project leaders’ qualifications,
the project leaders were categorized into
three labor categories: Social Scientists
and Related Workers; Epidemiologists;
mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Data collection activity

and Medical Scientists. For example,
one project director conducting a
randomized controlled trial is a
physician and was categorized into the
Medical Scientist labor category. Other
project leaders have advanced degrees
in the social sciences (e.g., gerontology)
or epidemiology and were included in

the Social Scientist or Epidemiologist
labor categories, as appropriate.
Exhibit 2 shows the estimated
annualized cost burden associated with
the respondent’s time to participate in
the evaluation. The total cost burden is
estimated to be $3,450.

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents

Data collection activity
Interviews with contractors ..............................................................
Interviews with grantees ..................................................................

VerDate Mar<15>2010

16:17 Apr 05, 2012

Jkt 226001

PO 00000

Frm 00043

Fmt 4703

Total burden
hours
40
18

Sfmt 4703

Average hourly
wage rate*

60
27

E:\FR\FM\06APN1.SGM

06APN1

$39.66
39.66

Total cost burden
$2,380
1,070

20822

Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents

Data collection activity
Total ..........................................................................................

Total burden
hours
58

Average hourly
wage rate*

87

Total cost burden

n/a

3,450

*Base

upon the weighted average of the mean wages for 19–3099 Social Scientists and Related Workers, All Other ($37.45 per hour; n = 17),
19–1041 Epidemiologists ($32.83; n = 5) and 19–1042 Medical Scientists (($41.69; n = 36), National Compensation Survey: Occupational Wages
in the United States May 2010, U.S. Department of Labor, Bureau of Labor Statistics.

Estimated Annual Costs to the Federal
Government
Exhibit 3 shows the estimated total
and annualized cost to the government
for conducting the evaluation. The total
cost is estimated to be $87,502.

EXHIBIT 3—ESTIMATED TOTAL AND
ANNUALIZED COST
Cost component

mstockstill on DSK4VPTVN1PROD with NOTICES

Project Development ..................
Data Collection Activities ................
Data Processing
and Analysis ......
Publication of Results ...................
Project Management ..................
Overhead ..............

Annualized
cost

Total cost

$6,135

$2,045

17,400

5,800

Dated: March 29, 2012.
Carolyn M. Clancy,
Director.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2012–8098 Filed 4–5–12; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review

The meeting announced below
concerns Detecting Emerging VectorBorne Zoonotic Pathogens in Indonesia,
0
0 Funding Opportunity Announcement
(FOA) CK12–002, initial review.
5,800
1,933
Correction: The notice was published
29,167
9,722
in the Federal Register on March 2,
Total ...............
87,502
29,167 2012, Volume 77, Number 42, Page
12844. The time and date should read
as follows:
Request for Comments
Time and Date: 1 p.m.–3 p.m., April
In accordance with the Paperwork
16, 2012 (Closed).
Reduction Act, comments on AHRQ’s
Contact Person for More Information:
information collection are requested
Gregory Anderson, M.P.H., M.S.,
with regard to any of the following: (a)
Scientific Review Officer, CDC, 1600
Whether the proposed collection of
Clifton Road, NE., Mailstop E60,
information is necessary for the proper
Atlanta, Georgia 30333, Telephone:
performance of AHRQ healthcare
(404) 718–8833.
research and healthcare information
dissemination functions, including
The Director, Management Analysis
whether the information will have
and Services Office, has been delegated
practical utility; (b) the accuracy of
the authority to sign Federal Register
AHRQ’s estimate of burden (including
notices pertaining to announcements of
hours and costs) of the proposed
meetings and other committee
collection(s) of information; (c) ways to
management activities, for both the
enhance the quality, utility, and clarity
Centers for Disease Control and
of the information to be collected; and
Prevention and the Agency for Toxic
(d) ways to minimize the burden of the
Substances and Disease Registry.
collection of information upon the
Dated: March 30, 2012.
respondents, including the use of
Elaine
L. Baker,
automated collection techniques or
Director, Management Analysis and Services
other forms of information technology.
Office, Centers for Disease Control and
Comments submitted in response to
Prevention.
this notice will be summarized and
[FR Doc. 2012–8286 Filed 4–5–12; 8:45 am]
included in the Agency’s subsequent
BILLING CODE 4163–18–P
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.

VerDate Mar<15>2010

29,000

16:17 Apr 05, 2012

9,667

Jkt 226001

PO 00000

Frm 00044

Fmt 4703

Sfmt 9990

Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Identifying Modifiable
Protective Factors for Intimate Partner
Violence or Sexual Violence
Perpetration, Funding Opportunity
Announcement (FOA) CE12–003, Initial
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–3 p.m., April 26,
2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Identifying Modifiable
Protective Factors for Intimate Partner
Violence or Sexual Violence Perpetration,
FOA CE12–003’’.
Contact Person for More Information: Jane
Suen, Dr.P.H., M.S., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F63, Atlanta, Georgia 30341–3724,
Telephone (770) 488–4281.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 30, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–8285 Filed 4–5–12; 8:45 am]
BILLING CODE 4163–18–P

E:\FR\FM\06APN1.SGM

06APN1